1. Home
  2. SEM vs NRIX Comparison

SEM vs NRIX Comparison

Compare SEM & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Select Medical Holdings Corporation

SEM

Select Medical Holdings Corporation

HOLD

Current Price

$16.27

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.81

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEM
NRIX
Founded
1996
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
SEM
NRIX
Price
$16.27
$14.81
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$15.17
$30.58
AVG Volume (30 Days)
3.1M
785.4K
Earning Date
04-30-2026
04-07-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$5.45
N/A
Revenue Next Year
$4.78
$26.32
P/E Ratio
$14.02
N/A
Revenue Growth
N/A
99.31
52 Week Low
$11.65
$8.18
52 Week High
$18.61
$22.50

Technical Indicators

Market Signals
Indicator
SEM
NRIX
Relative Strength Index (RSI) 63.73 40.32
Support Level $16.20 $11.34
Resistance Level $16.30 $16.47
Average True Range (ATR) 0.04 0.81
MACD 0.00 -0.02
Stochastic Oscillator 70.00 15.86

Price Performance

Historical Comparison
SEM
NRIX

About SEM Select Medical Holdings Corporation

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: